These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 821599)
1. Combined diphosphonate and calcitonin therapy for Paget's disease of bone. Hosking DJ; Bijvoet OL Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599 [No Abstract] [Full Text] [Related]
2. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. Smith R; Russell RG; Bishop MC; Woods CG; Bishop M Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518 [No Abstract] [Full Text] [Related]
3. Paget's bone disease treated with diphosphonate and calcitonin. Hosking DJ; Bijvoet OL; van Aken J; Will EJ Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896 [TBL] [Abstract][Full Text] [Related]
8. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Nuti R; Turchetti V; Righi G; Vattimo A Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555 [TBL] [Abstract][Full Text] [Related]
9. Letter: Diphosphonate and calcitonin in Paget's disease. Hosking DJ; Bijvoet OL Lancet; 1976 May; 1(7966):970. PubMed ID: 57380 [No Abstract] [Full Text] [Related]
10. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP). De Vries HR; Bijvoet OL Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525 [No Abstract] [Full Text] [Related]
11. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876 [No Abstract] [Full Text] [Related]
12. [Etidronic acid therapy in Paget's disease of bone]. Holz G; Delling G; Ziegler R Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505 [TBL] [Abstract][Full Text] [Related]
13. [Non-hormonal drug treatment in Paget's disease]. Ryckewaert A; Lemaire V; Tubiana M Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365 [TBL] [Abstract][Full Text] [Related]
14. Paget's disease: state of the art. Avioli LV Clin Ther; 1987; 9(6):567-76. PubMed ID: 2964271 [No Abstract] [Full Text] [Related]
15. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Rashid M; Khairi A; Johnston C Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576 [No Abstract] [Full Text] [Related]
16. Diphosphonates in Paget's disease. Russell RG; Smith R; Preston C; Walton RJ; Woods CG Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419 [No Abstract] [Full Text] [Related]
17. Therapeutic success in Paget disease. Vaisrub S JAMA; 1973 Jun; 224(10):1413. PubMed ID: 4634178 [No Abstract] [Full Text] [Related]
18. Synthetic human calcitonin in refractory Paget's disease of bone. Altman RD; Collins-Yudiskas B Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398 [TBL] [Abstract][Full Text] [Related]
19. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease]. Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study]. Eisinger J; Laponche AM; Ouaniche J Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204 [No Abstract] [Full Text] [Related] [Next] [New Search]